Hotze Anna C G, van der Geer Erwin P L, Caspers Sabrine E, Kooijman Huub, Spek Anthony L, Haasnoot Jaap G, Reedijk Jan
Gorlaeus Laboratories, Leiden Institute of Chemistry, Leiden University, P.O. Box 9502, 2300 RA Leiden, The Netherlands.
Inorg Chem. 2004 Aug 9;43(16):4935-43. doi: 10.1021/ic035390f.
The striking difference in cytotoxic activity between the inactive cis-[Ru(bpy)(2)Cl(2)] and the recently reported highly cytotoxic alpha-[Ru(azpy)(2)Cl(2)] (alpha indicating the isomer in which the coordinating Cl atoms, pyridine nitrogens, and azo nitrogens are in mutual cis, trans, cis orientation) encouraged the synthesis of the mixed-ligand compound cis-[Ru(azpy)(bpy)Cl(2)]. The synthesis and characterization of the only occurring isomer, i.e., alpha-[Ru(azpy)(bpy)Cl(2)], 1 (alpha denoting the isomer in which the Cl ligands are cis related to each other and the pyridine ring of azpy is trans to the pyridine ring of bpy), are described. The solid-state structure of 1 has been determined by X-ray structure analysis. The IC(50) values obtained for several human tumor cell lines have indicated that compound 1 shows mostly a low to moderate cytotoxicity. The binding of the DNA model base 9-ethylguanine (9-EtGua) to the hydrolyzed species of 1 has been studied and compared to DNA model base binding studies of cis-[Ru(bpy)(2)Cl(2)] and alpha-[Ru(azpy)(2)Cl(2)]. The completely hydrolyzed species of 1, i.e., alpha-Ru(azpy)(bpy)(H(2)O)(2), has been reacted with 9-EtGua in water at room temperature for 24 h. This resulted in the monofunctional binding of only one 9-EtGua, coordinated via the N7 atom. The product has been isolated as alpha-Ru(azpy)(bpy)(9-EtGua)(H(2)O)(2), 2, and characterized by 2D NOESY NMR spectroscopy. The NOE data show that the 9-EtGua coordinates (under these conditions) at the position trans to the azo nitrogen atom. Surprisingly, time-dependent (1)H NMR data of the 9-EtGua adduct 2 in acetone-d(6) show an unprecedented positional shift of the 9-EtGua from the position trans to the azo nitrogen to the position trans to the bpy nitrogen atom, resulting in the adduct alpha'-Ru(azpy)(bpy)(9-EtGua)(H(2)O)(2) (alpha' indicating 9-EtGua is trans to the bpy nitrogen). This positional isomerization of 9-EtGua is correlated to the cytotoxicity of 1 in comparison to both the cytotoxicity and 9-EtGua coordination of cis-[Ru(bpy)(2)Cl(2)], alpha-[Ru(azpy)(2)Cl(2)], and beta-[Ru(azpy)(2)Cl(2)]. This positional isomerization process is unprecedented in model base metal chemistry and could be of considerable biological significance.
无活性的顺式-[Ru(bpy)(2)Cl(2)]与最近报道的具有高细胞毒性的α-[Ru(azpy)(2)Cl(2)](α表示配位的Cl原子、吡啶氮原子和偶氮氮原子处于顺、反、顺相互取向的异构体)之间细胞毒性活性的显著差异,促使人们合成了混合配体化合物顺式-[Ru(azpy)(bpy)Cl(2)]。本文描述了唯一存在的异构体即α-[Ru(azpy)(bpy)Cl(2)](1)(α表示Cl配体彼此顺式相关且azpy的吡啶环与bpy的吡啶环反式的异构体)的合成与表征。通过X射线结构分析确定了1的固态结构。对几种人类肿瘤细胞系获得的IC(50)值表明化合物1大多表现出低至中等的细胞毒性。研究了DNA模型碱基9-乙基鸟嘌呤(9-EtGua)与1的水解产物的结合,并与顺式-[Ru(bpy)(2)Cl(2)]和α-[Ru(azpy)(2)Cl(2)]的DNA模型碱基结合研究进行了比较。1的完全水解产物即α-Ru(azpy)(bpy)(H(2)O)(2)在室温下于水中与9-EtGua反应24小时。这导致仅一个9-EtGua通过N7原子配位的单功能结合。产物被分离为α-Ru(azpy)(bpy)(9-EtGua)(H(2)O)(2)(2),并通过二维NOESY NMR光谱进行了表征。NOE数据表明9-EtGua(在这些条件下)在与偶氮氮原子反式的位置配位。令人惊讶的是,9-EtGua加合物2在丙酮-d(6)中的时间依赖性(1)H NMR数据显示9-EtGua出现了前所未有的位置移动,从与偶氮氮原子反式的位置移动到与bpy氮原子反式的位置,形成加合物α'-Ru(azpy)(bpy)(9-EtGua)(H(2)O)(2)(α'表示9-EtGua与bpy氮原子反式)。与顺式-[Ru(bpy)(2)Cl(2)]、α-[Ru(azpy)(2)Cl(2)]和β-[Ru(azpy)(2)Cl(2)]的细胞毒性以及9-EtGua配位相比,9-EtGua的这种位置异构化与1的细胞毒性相关。这种位置异构化过程在模型碱基金属化学中是前所未有的,可能具有相当大的生物学意义。